ACE concentration above the median (104 ng/ml) was also associated with greater odds of severe persistent AKI (OR 7.9, 95%CI 2.0–31, p = 0.001) and KRT use (OR 6.5, 95%CI 1.3–32, p = 0.011) (Table 1). This evidence concerns the gene ACE and acute kidney injury.